3055B |
Mexiletine, Blood |
3055SP |
Mexiletine, Serum/Plasma |
3060U |
N,N-Dimethylacetamide Exposure (N-Methylacetamide), Urine |
3070U |
N,N-Dimethylformamide (DMF) Exposure (N-Monomethylformamide), Urine |
3080U |
MOCA, Urine |
3081U |
MOCA and MDA Exposure Profile, Urine |
3082B |
Molindone, Blood |
3082SP |
Molindone, Serum/Plasma |
3082U |
Molindone, Urine |
3092SP |
Moricizine, Serum/Plasma |
3098U |
Mono-n-butyl phthalate (MNBP), Urine |
3157U |
Cotinine and Anabasine from Secondary Exposure, Urine |
3225SP |
Nuedexta®, Serum/Plasma |
3226B |
Olanzapine and Metabolite, Blood |
3226FL |
Olanzapine, Fluid |
3226SP |
Olanzapine and Metabolite, Serum/Plasma |
3226TI |
Olanzapine, Tissue |
3227B |
Beta-Blockers Panel, Blood |
3227SP |
Beta-Blockers Panel, Serum/Plasma |
3227U |
Beta-Blockers Panel, Urine |
3250SP |
Oxalate, Serum/Plasma |
3440B |
Perphenazine, Blood |
3440SP |
Perphenazine, Serum/Plasma |
3776B |
Pimozide, Blood |
3776SP |
Pimozide, Serum/Plasma |
3950B |
Prochlorperazine, Blood |
3950SP |
Prochlorperazine, Serum/Plasma |
3976B |
Propafenone, Blood |
3976SP |
Propafenone, Serum/Plasma |